Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: A matched cohort study

Nephrology Dialysis Transplantation

Volumn 30, Issue 5, 2015, Pages 829-835

  Pun, Patrick H ^a,b   Hellkamp, Anne S ^a   Sanders, Gillian D ^a   Middleton, John P ^b   Hammill, Stephen C ^c   Al Khalidi, Hussein R ^a   Curtis, Lesley H ^a   Fonarow, Gregg C ^d   Al Khatib, Sana M ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiovascular disease; defibrillator; dialysis; endstage kidney disease; sudden cardiac death

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY PREVENTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; SURVIVAL TIME; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; COMPLICATION; DEATH, SUDDEN, CARDIAC; HEART FAILURE; INCIDENCE; MIDDLE AGED; PROCEDURES; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PRIMARY PREVENTION; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 84929580380     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu274     Document Type: Article

References (21)

1. Pun PH, Middleton JP. Sudden cardiac death in hemodialysis patients: A comprehensive care approach to reduce risk. Blood Purif 2012; 33: 183-189
2. Pun PH, Smarz TR, Honeycutt EF et al. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int 2009; 76: 652-658
3. Russo AM, Stainback RF, Bailey SR et al. ACCF/HRS/AHA/ASE/HFSA/ SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: A report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Heart Rhythm 2013; 10: e11-e58
4. Charytan DM, Patrick AR, Liu J et al. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis 2011; 58: 409-417
5. Aggarwal A, Wang Y, Rumsfeld JS et al. Clinical characteristics and inhospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm 2009; 6: 1565-1571
6. Messenger JC, Ho KK, Young CH et al. The National Cardiovascular Data Registry (NCDR) Data Quality Brief: The NCDR Data Quality Program in 2012. J Am Coll Cardiol 2012; 60: 1484-1488
7. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41-55
8. Goldenberg I, Moss AJ, McNitt S et al. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006; 98: 485-490
9. Makki N, Swaminathan PD, Hanmer J et al. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies. Europace 2014; 16: 55-62
10. Hage FG, Aljaroudi W, Aggarwal H et al. Outcomes of patients with chronic kidney disease and implantable cardiac defibrillator: primary versus secondary prevention. Int J Cardiol 2013; 165: 113-116
11. Pun PH, Al-Khatib SM, Han JY et al. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: A meta-analysis of patient-level data from 3 randomized trials. Am J Kidney Dis 2014; 64: 32-39
12. Sakhuja R, Keebler M, Lai TS et al. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol 2009; 103: 735-741
13. Dasgupta A, Montalvo J, Medendorp S et al. Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 2007; 49: 656-663
14. Lafrance JP, Nolin L, Senecal L et al. Predictors and outcome of cardiopulmonary resuscitation (CPR) calls in a large haemodialysis unit over a seven-year period. Nephrol Dial Transplant 2006; 21: 1006-1012
15. Wan C, Herzog CA, ZarebaWet al. Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator. Ann Noninvasive Electrocardiol 2014; 19: 247-257
16. Alsheikh-Ali AA, Trikalinos TA, Ruthazer R et al. Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease. Am Heart J 2011; 161: 204-209 e1
17. Wase A, Basit A, Nazir R et al. Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol 2004; 11: 199-204
18. Bleyer AJ, Hartman J, Brannon PC et al. Characteristics of sudden death in hemodialysis patients. Kidney Int 2006; 69: 2268-2273
19. Mangrum AJ, Liu D, Dimarco JP et al. Sudden cardiac death and left ventricular function in hemodialysis patients. Heart Rhythm 2005; 2: S41
20. Paoletti E, Specchia C, Di Maio G et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: A 10 year survey. Nephrol Dial Transplant 2004; 19: 1829-1834
21. de Bie MK, Lekkerkerker JC, van Dam B et al. Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial-A prospective pilot study. Curr Med Res Opin 2008; 24: 2151-2157